PMID: 38961Jun 1, 1979

Activities of NAD-specific and NADP-specific isocitrate dehydrogenases in rat-liver mitochondria. Studies with D-threo-alpha-methylisocitrate

European Journal of Biochemistry
C M Smith, G W Plaut


The contributions of NAD-specific and NADP-specific isocitrate dehydrogenases to isocitrate oxidation in isolated intact rat liver mitochondria were examined using DL-threo-alpha-methylisocitrate (3-hydroxy-1,2,3-butanetricarboxylate) to specifically inhibit flux through NADP-specific isocitrate dehydrogenase. Under a range of conditions tested with respiring mitochondria, the rate of isocitrate oxidation was decreased by about 20--40% by inhibition of NADP-isocitrate dehydrogenase, and matrix NADP became more oxidized. (a) For mitochondria incubated with externally added DL-isocitrate and citrate, the rate of isocitrate oxidation obtained by extrapolation to infinite alpha-methylisocitrate concentration was approximately 70% of the uninhibited rate in both state 3 and state 4. (b) With pyruvate plus malate added as substrates of citric acid cycle oxidation and isocitrate generated intramitochondrially, a concentration of alpha-methylisocitrate (400 microM) sufficient for 99.99% inhibition of NADP-isocitrate dehydrogenase inhibited isocitrate oxidation in states 4 and 3 by 21 +/- 6% and 19 +/- 11% (mean +/- SEM), respectively. (c) With externally added isocitrate and citrate, the addition of NH4Cl increased isocitrate oxidation...Continue Reading


Oct 1, 1991·Journal of Bioenergetics and Biomembranes·J B Jackson
Nov 1, 1990·Plant Physiology·A G Rasmusson, I M Møller
Oct 1, 1993·Acta Physiologica Scandinavica·J M LawlerD S Criswell
May 6, 2009·Biochimica Et Biophysica Acta·Richard M Denton
Nov 1, 1983·The British Journal of Nutrition·M F Palmer, B A Rolls
Sep 20, 2017·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·Y-R KimU-K Kim


Aug 1, 1976·European Journal of Biochemistry·E LenartowiczA B Wojtczak
Mar 1, 1976·Biophysical Journal·A WilkinsonW Lund
Jun 28, 1973·Biochimica Et Biophysica Acta·J B HoekL ERNSTER
Jan 1, 1964·Biochemical and Biophysical Research Communications·B KadenbachM Klingenberg
Aug 23, 1967·Biochemical and Biophysical Research Communications·G W Plaut, T Aogaichi
Sep 1, 1969·The Biochemical Journal·P B Nicholls DG RAND
Oct 27, 1970·Biochimica Et Biophysica Acta·R A Chamalaun, J M Tager
Apr 8, 1969·Biochimica Et Biophysica Acta·R KraaijenhofK van Dam
Dec 1, 1954·The Biochemical Journal·P G WALKER
Aug 1, 1956·Experimental Cell Research·L ERNSTER, F NAVAZIO
Nov 1, 1957·Biochimica Et Biophysica Acta·L ERNSTER, F NAVAZIO
Nov 1, 1958·Biochimica Et Biophysica Acta·J L PURVIS
Mar 4, 1961·Biochimica Et Biophysica Acta·P V VIGNAIS, P M VIGNAIS
Feb 12, 1960·Biochimica Et Biophysica Acta·L ERNSTER, A J GLASKY
Mar 1, 1965·The Biochemical Journal·C W OWENS, R V BELCHER
Aug 1, 1956·Proceedings of the National Academy of Sciences of the United States of America·N O KaplanM M Ciotti

Related Concepts

Mitochondria, Liver
Ketoglutaric Acids
Isocitrate Dehydrogenase-I
Oxygen Consumption
Ammonium Chloride
Citric Acid Cycle

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.